Back
EPAM Systems, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
36
EPAM
EPAM Systems, Inc.
Last Price:
$207.03
Seasonality Move:
-0.13%
Sell
20
NVO
Novo Nordisk A/S
Last Price:
$47.60
Seasonality Move:
4.04%
Sell
36
EPAM Systems, Inc. (EPAM)
is a Sell
Is EPAM Systems, Inc. a Buy, Sell or Hold?
-
The current EPAM Systems, Inc. [EPAM] share price is $207.02. The Score for EPAM is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $47.61. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EPAM Stock Price Chart
What is EPAM Systems, Inc.'s stock price today?
-
The EPAM Systems, Inc. share price today is $207.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $47.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
EPAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.2 | Buy |
| Relative Strength Index (14 RSI): | 68.3 | Buy |
| Chaikin Money Flow: | 506542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (181.91 - 206.83) | Buy |
| Bollinger Bands (100): | (149.62 - 186.4) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 44.82 | Sell |
| Chaikin Money Flow: | -6318846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.96 - 49.4) | Sell |
| Bollinger Bands (100): | (48.16 - 56.94) | Sell |
EPAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.72 | Sell |
| 20-day SMA: | 198.11 | Buy |
| 50-day SMA: | 176.5 | Buy |
| 200-day SMA: | 169.42 | Buy |
| 8-day EMA: | 206.29 | Buy |
| 20-day EMA: | 198.75 | Buy |
| 50-day EMA: | 184.16 | Buy |
| 200-day EMA: | 179.39 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.82 | Sell |
| 20-day SMA: | 48.1 | Sell |
| 50-day SMA: | 50.21 | Sell |
| 200-day SMA: | 61.08 | Sell |
| 8-day EMA: | 48.51 | Sell |
| 20-day EMA: | 48.56 | Sell |
| 50-day EMA: | 50.31 | Sell |
| 200-day EMA: | 63.25 | Sell |
EPAM Systems, Inc. Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $1.02 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and a decrease next year of $0.15 per share.
EPAM Systems, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||